Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases
L. Zhang, L. Li, P. Andell, et al. (2024)
JAMA Psychiatry 81(2), 178-187
Abstract
Swedish register study on long-term cardiovascular safety of ADHD medication. Small absolute increase in risk of hypertension and arterial disease, supporting routine blood pressure and heart rate monitoring.
Categories: ADHS bei Erwachsenen, Medikamente
Keywords: register study, long-term safety, blood pressure, cardiovascular, monitoring